Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Cyclodextrins in Pharmaceutical should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Cyclodextrins in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Cyclodextrins in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Solid segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Drug Safety has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Cyclodextrins in Pharmaceutical include Ashland, Cambrex Corporation, Cayman Chemical, Cyclo Therapeutics, Ligand Pharmaceuticals Incorporated, Merck KGaA, Midas Pharma GmbH, Otto Chemie and TCI Chemicals, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Cyclodextrins are cyclic oligomers of glucose that have a significant number of applications in the pharmaceutical industries. Water-soluble cyclodextrins can form inclusion complexes with small molecules and portions of large compounds that have limited aqueous solubility to provide improved bioavailability of drugs.
This report aims to provide a comprehensive study of the global market for Cyclodextrins in Pharmaceutical. Report Highlights:
(1) Global Cyclodextrins in Pharmaceutical market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Cyclodextrins in Pharmaceutical market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Cyclodextrins in Pharmaceutical market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Cyclodextrins in Pharmaceutical segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Cyclodextrins in Pharmaceutical segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Cyclodextrins in Pharmaceutical, capacity, production and trends.
(7) Cyclodextrins in Pharmaceutical industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Solid
Liquid
Market segment by application, can be divided into
Drug Safety
Medical Laboratory
Others
Market segment by players, this report covers
Ashland
Cambrex Corporation
Cayman Chemical
Cyclo Therapeutics
Ligand Pharmaceuticals Incorporated
Merck KGaA
Midas Pharma GmbH
Otto Chemie
TCI Chemicals
VIO CHEMICALS
Wacker Chemie AG
Wellona Pharma
1 Market Overview
1.1 Cyclodextrins in Pharmaceutical Definition
1.2 Global Cyclodextrins in Pharmaceutical Market Size and Forecast
1.2.1 By Revenue, Global Cyclodextrins in Pharmaceutical Market Size, 2018-2029
1.2.2 By Sales Volume, Global Cyclodextrins in Pharmaceutical Market Size, 2018-2029
1.2.3 Global Cyclodextrins in Pharmaceutical Price Trend, 2018-2029
1.3 China Cyclodextrins in Pharmaceutical Market Size and Forecast
1.3.1 By Revenue, China Cyclodextrins in Pharmaceutical Market Size, 2018-2029
1.3.2 By Sales Volume, China Cyclodextrins in Pharmaceutical Market Size, 2018-2029
1.3.3 China Cyclodextrins in Pharmaceutical Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Cyclodextrins in Pharmaceutical Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Cyclodextrins in Pharmaceutical Share in Global Market, 2018-2029
1.4.3 Cyclodextrins in Pharmaceutical Market Size: China VS Global, 2018-2029
1.5 Cyclodextrins in Pharmaceutical Market Dynamics
1.5.1 Cyclodextrins in Pharmaceutical Market Drivers
1.5.2 Cyclodextrins in Pharmaceutical Market Restraints
1.5.3 Cyclodextrins in Pharmaceutical Industry Trends
1.5.4 Cyclodextrins in Pharmaceutical Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Cyclodextrins in Pharmaceutical Revenue by Company, 2018-2023
2.2 Global Cyclodextrins in Pharmaceutical Sales Volume by Company, 2018-2023
2.3 Global Cyclodextrins in Pharmaceutical Price by Company, 2018-2023
2.4 Global Cyclodextrins in Pharmaceutical Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Cyclodextrins in Pharmaceutical Concentration Ratio
2.6 Global Cyclodextrins in Pharmaceutical Mergers & Acquisitions, Expansion Plans
2.7 Global Cyclodextrins in Pharmaceutical Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Cyclodextrins in Pharmaceutical Revenue by Company, 2018-2023
3.2 China Cyclodextrins in Pharmaceutical Sales Volume by Company, 2018-2023
3.3 China Cyclodextrins in Pharmaceutical Cyclodextrins in Pharmaceutical Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Cyclodextrins in Pharmaceutical Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Cyclodextrins in Pharmaceutical Domestic VS Export
3.6 China Market, Cyclodextrins in Pharmaceutical Import & Export
3.6.1 China Market, Cyclodextrins in Pharmaceutical Import & Export, 2018-2029
3.6.2 China Cyclodextrins in Pharmaceutical Import & Export Trends
3.6.3 Main Sources of China Cyclodextrins in Pharmaceutical Import
3.6.4 Export Destination of China Cyclodextrins in Pharmaceutical
4 Cyclodextrins in Pharmaceutical Production by Region
4.1 Global Cyclodextrins in Pharmaceutical Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Cyclodextrins in Pharmaceutical Manufacturers
4.3 Global Major Manufacturers, Cyclodextrins in Pharmaceutical Capacity Expansion and Future Plans
4.4 Global Cyclodextrins in Pharmaceutical Capacity by Region
4.5 Global Cyclodextrins in Pharmaceutical Production by Region
4.5.1 Global Cyclodextrins in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Cyclodextrins in Pharmaceutical Production by Region, 2018-2023
4.5.3 Global Cyclodextrins in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Cyclodextrins in Pharmaceutical Industry Chain
5.2 Cyclodextrins in Pharmaceutical Upstream Analysis
5.2.1 Cyclodextrins in Pharmaceutical Core Raw Materials
5.2.2 Main Manufacturers of Cyclodextrins in Pharmaceutical Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Cyclodextrins in Pharmaceutical Production Mode
5.6 Cyclodextrins in Pharmaceutical Procurement Model
5.7 Cyclodextrins in Pharmaceutical Industry Sales Model and Sales Channels
5.7.1 Cyclodextrins in Pharmaceutical Sales Model
5.7.2 Cyclodextrins in Pharmaceutical Typical Distributors
6 Sights by Type
6.1 Cyclodextrins in Pharmaceutical Classification
6.1.1 Solid
6.1.2 Liquid
6.2 By Type, Global Cyclodextrins in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029
6.4 By Type, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029
6.5 By Type, Global Cyclodextrins in Pharmaceutical Price, 2018-2029
7 Sights by Application
7.1 Cyclodextrins in Pharmaceutical Segment by Application
7.1.1 Drug Safety
7.1.2 Medical Laboratory
7.1.3 Others
7.2 By Application, Global Cyclodextrins in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029
7.4 By Application, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029
7.5 By Application, Global Cyclodextrins in Pharmaceutical Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Cyclodextrins in Pharmaceutical Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029
8.3 By Region, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Cyclodextrins in Pharmaceutical Market Size Market Share
8.5 Europe
8.5.1 Europe Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Cyclodextrins in Pharmaceutical Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Cyclodextrins in Pharmaceutical Market Size Market Share
8.7 South America
8.7.1 South America Cyclodextrins in Pharmaceutical Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Cyclodextrins in Pharmaceutical Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Cyclodextrins in Pharmaceutical Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029
9.3 By Country, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.4.2 By Company, U.S. Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.5.2 By Company, Europe Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.5.3 By Type, Europe Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.6.2 By Company, China Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.6.3 By Type, China Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.7.2 By Company, Japan Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.7.3 By Type, Japan Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.8.2 By Company, South Korea Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.10.2 By Company, India Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.10.3 By Type, India Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Cyclodextrins in Pharmaceutical Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Cyclodextrins in Pharmaceutical Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Ashland
10.1.1 Ashland Company Information, Head Office, Market Area and Industry Position
10.1.2 Ashland Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.1.3 Ashland Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Ashland Company Profile and Main Business
10.1.5 Ashland Recent Developments
10.2 Cambrex Corporation
10.2.1 Cambrex Corporation Company Information, Head Office, Market Area and Industry Position
10.2.2 Cambrex Corporation Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.2.3 Cambrex Corporation Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Cambrex Corporation Company Profile and Main Business
10.2.5 Cambrex Corporation Recent Developments
10.3 Cayman Chemical
10.3.1 Cayman Chemical Company Information, Head Office, Market Area and Industry Position
10.3.2 Cayman Chemical Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.3.3 Cayman Chemical Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Cayman Chemical Company Profile and Main Business
10.3.5 Cayman Chemical Recent Developments
10.4 Cyclo Therapeutics
10.4.1 Cyclo Therapeutics Company Information, Head Office, Market Area and Industry Position
10.4.2 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.4.3 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Cyclo Therapeutics Company Profile and Main Business
10.4.5 Cyclo Therapeutics Recent Developments
10.5 Ligand Pharmaceuticals Incorporated
10.5.1 Ligand Pharmaceuticals Incorporated Company Information, Head Office, Market Area and Industry Position
10.5.2 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.5.3 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Ligand Pharmaceuticals Incorporated Company Profile and Main Business
10.5.5 Ligand Pharmaceuticals Incorporated Recent Developments
10.6 Merck KGaA
10.6.1 Merck KGaA Company Information, Head Office, Market Area and Industry Position
10.6.2 Merck KGaA Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.6.3 Merck KGaA Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Merck KGaA Company Profile and Main Business
10.6.5 Merck KGaA Recent Developments
10.7 Midas Pharma GmbH
10.7.1 Midas Pharma GmbH Company Information, Head Office, Market Area and Industry Position
10.7.2 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.7.3 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Midas Pharma GmbH Company Profile and Main Business
10.7.5 Midas Pharma GmbH Recent Developments
10.8 Otto Chemie
10.8.1 Otto Chemie Company Information, Head Office, Market Area and Industry Position
10.8.2 Otto Chemie Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.8.3 Otto Chemie Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Otto Chemie Company Profile and Main Business
10.8.5 Otto Chemie Recent Developments
10.9 TCI Chemicals
10.9.1 TCI Chemicals Company Information, Head Office, Market Area and Industry Position
10.9.2 TCI Chemicals Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.9.3 TCI Chemicals Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 TCI Chemicals Company Profile and Main Business
10.9.5 TCI Chemicals Recent Developments
10.10 VIO CHEMICALS
10.10.1 VIO CHEMICALS Company Information, Head Office, Market Area and Industry Position
10.10.2 VIO CHEMICALS Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.10.3 VIO CHEMICALS Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 VIO CHEMICALS Company Profile and Main Business
10.10.5 VIO CHEMICALS Recent Developments
10.11 Wacker Chemie AG
10.11.1 Wacker Chemie AG Company Information, Head Office, Market Area and Industry Position
10.11.2 Wacker Chemie AG Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.11.3 Wacker Chemie AG Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Wacker Chemie AG Company Profile and Main Business
10.11.5 Wacker Chemie AG Recent Developments
10.12 Wellona Pharma
10.12.1 Wellona Pharma Company Information, Head Office, Market Area and Industry Position
10.12.2 Wellona Pharma Cyclodextrins in Pharmaceutical Models, Specifications and Application
10.12.3 Wellona Pharma Cyclodextrins in Pharmaceutical Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Wellona Pharma Company Profile and Main Business
10.12.5 Wellona Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Cyclodextrins in Pharmaceutical Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Cyclodextrins in Pharmaceutical Market Restraints
Table 3. Cyclodextrins in Pharmaceutical Market Trends
Table 4. Cyclodextrins in Pharmaceutical Industry Policy
Table 5. Global Cyclodextrins in Pharmaceutical Revenue by Company, 2018-2023, US$ million
Table 6. Global Cyclodextrins in Pharmaceutical Revenue Market Share by Company, 2018-2023
Table 7. Global Cyclodextrins in Pharmaceutical Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Cyclodextrins in Pharmaceutical Sales Volume Market Share by Company, 2018-2023
Table 9. Global Cyclodextrins in Pharmaceutical Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Cyclodextrins in Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Cyclodextrins in Pharmaceutical Mergers & Acquisitions, Expansion Plans
Table 12. Global Cyclodextrins in Pharmaceutical Manufacturers Product Type
Table 13. China Cyclodextrins in Pharmaceutical Revenue by Company, 2018-2023, US$ million
Table 14. China Cyclodextrins in Pharmaceutical Revenue Market Share by Company, 2018-2023
Table 15. China Cyclodextrins in Pharmaceutical Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Cyclodextrins in Pharmaceutical Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Cyclodextrins in Pharmaceutical Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Cyclodextrins in Pharmaceutical Import & Export Trends
Table 19. Main Sources of China Cyclodextrins in Pharmaceutical Import
Table 20. Export Destination of China Cyclodextrins in Pharmaceutical
Table 21. Global Headquarters and Manufacturing Base of Cyclodextrins in Pharmaceutical Manufacturers
Table 22. Global Major Manufacturers, Cyclodextrins in Pharmaceutical Capacity Expansion and Future Plans
Table 23. Global Cyclodextrins in Pharmaceutical Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Cyclodextrins in Pharmaceutical Production by Region, 2018-2023, (K Units)
Table 25. Global Cyclodextrins in Pharmaceutical Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Cyclodextrins in Pharmaceutical Upstream (Raw Materials)
Table 27. Global Cyclodextrins in Pharmaceutical Typical Customers
Table 28. Cyclodextrins in Pharmaceutical Typical Distributors
Table 29. By Type, Global Cyclodextrins in Pharmaceutical Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Cyclodextrins in Pharmaceutical Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Cyclodextrins in Pharmaceutical Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Cyclodextrins in Pharmaceutical Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Cyclodextrins in Pharmaceutical Revenue Market Share, 2018-2029
Table 37. By Country, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2018-2029
Table 39. Ashland Company Information, Head Office, Market Area and Industry Position
Table 40. Ashland Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 41. Ashland Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Ashland Company Profile and Main Business
Table 43. Ashland Recent Developments
Table 44. Cambrex Corporation Company Information, Head Office, Market Area and Industry Position
Table 45. Cambrex Corporation Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 46. Cambrex Corporation Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Cambrex Corporation Company Profile and Main Business
Table 48. Cambrex Corporation Recent Developments
Table 49. Cayman Chemical Company Information, Head Office, Market Area and Industry Position
Table 50. Cayman Chemical Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 51. Cayman Chemical Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Cayman Chemical Company Profile and Main Business
Table 53. Cayman Chemical Recent Developments
Table 54. Cyclo Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 55. Cyclo Therapeutics Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 56. Cyclo Therapeutics Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Cyclo Therapeutics Company Profile and Main Business
Table 58. Cyclo Therapeutics Recent Developments
Table 59. Ligand Pharmaceuticals Incorporated Company Information, Head Office, Market Area and Industry Position
Table 60. Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 61. Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Ligand Pharmaceuticals Incorporated Company Profile and Main Business
Table 63. Ligand Pharmaceuticals Incorporated Recent Developments
Table 64. Merck KGaA Company Information, Head Office, Market Area and Industry Position
Table 65. Merck KGaA Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 66. Merck KGaA Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Merck KGaA Company Profile and Main Business
Table 68. Merck KGaA Recent Developments
Table 69. Midas Pharma GmbH Company Information, Head Office, Market Area and Industry Position
Table 70. Midas Pharma GmbH Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 71. Midas Pharma GmbH Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Midas Pharma GmbH Company Profile and Main Business
Table 73. Midas Pharma GmbH Recent Developments
Table 74. Otto Chemie Company Information, Head Office, Market Area and Industry Position
Table 75. Otto Chemie Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 76. Otto Chemie Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Otto Chemie Company Profile and Main Business
Table 78. Otto Chemie Recent Developments
Table 79. TCI Chemicals Company Information, Head Office, Market Area and Industry Position
Table 80. TCI Chemicals Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 81. TCI Chemicals Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. TCI Chemicals Company Profile and Main Business
Table 83. TCI Chemicals Recent Developments
Table 84. VIO CHEMICALS Company Information, Head Office, Market Area and Industry Position
Table 85. VIO CHEMICALS Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 86. VIO CHEMICALS Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. VIO CHEMICALS Company Profile and Main Business
Table 88. VIO CHEMICALS Recent Developments
Table 89. Wacker Chemie AG Company Information, Head Office, Market Area and Industry Position
Table 90. Wacker Chemie AG Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 91. Wacker Chemie AG Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Wacker Chemie AG Company Profile and Main Business
Table 93. Wacker Chemie AG Recent Developments
Table 94. Wellona Pharma Company Information, Head Office, Market Area and Industry Position
Table 95. Wellona Pharma Cyclodextrins in Pharmaceutical Models, Specifications and Application
Table 96. Wellona Pharma Cyclodextrins in Pharmaceutical Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Wellona Pharma Company Profile and Main Business
Table 98. Wellona Pharma Recent Developments
List of Figure
Figure 1. Cyclodextrins in Pharmaceutical Picture
Figure 2. By Revenue, Global Cyclodextrins in Pharmaceutical Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Cyclodextrins in Pharmaceutical Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Cyclodextrins in Pharmaceutical Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Cyclodextrins in Pharmaceutical Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Cyclodextrins in Pharmaceutical Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Cyclodextrins in Pharmaceutical Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Cyclodextrins in Pharmaceutical Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Cyclodextrins in Pharmaceutical Share of Global Market, 2018-2029
Figure 10. Global Cyclodextrins in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Cyclodextrins in Pharmaceutical Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Cyclodextrins in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Cyclodextrins in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Cyclodextrins in Pharmaceutical Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Cyclodextrins in Pharmaceutical Domestic VS Export, 2022
Figure 16. Global Cyclodextrins in Pharmaceutical Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Cyclodextrins in Pharmaceutical Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Cyclodextrins in Pharmaceutical Production Market Share & Forecast by Region, 2018-2029
Figure 19. Cyclodextrins in Pharmaceutical Industry Chain
Figure 20. Cyclodextrins in Pharmaceutical Procurement Model
Figure 21. Cyclodextrins in Pharmaceutical Sales Model
Figure 22. Cyclodextrins in Pharmaceutical Sales Channels, Direct Sales and Distribution
Figure 23. Solid
Figure 24. Liquid
Figure 25. By Type, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Cyclodextrins in Pharmaceutical Revenue Market Share, 2018-2029
Figure 27. By Type, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Cyclodextrins in Pharmaceutical Price, 2018-2029, (US$/Unit)
Figure 30. Drug Safety
Figure 31. Medical Laboratory
Figure 32. Others
Figure 33. By Application, Global Cyclodextrins in Pharmaceutical Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Cyclodextrins in Pharmaceutical Revenue Market Share, 2018-2029
Figure 35. By Application, Global Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Cyclodextrins in Pharmaceutical Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Cyclodextrins in Pharmaceutical Revenue Market Share, 2018-2029
Figure 39. By Region, Global Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2018-2029
Figure 40. North America Cyclodextrins in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Cyclodextrins in Pharmaceutical Revenue Market Share, 2022
Figure 42. Europe Cyclodextrins in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Cyclodextrins in Pharmaceutical Revenue Market Share, 2022
Figure 44. Asia Pacific Cyclodextrins in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Cyclodextrins in Pharmaceutical Revenue Market Share, 2022
Figure 46. South America Cyclodextrins in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Cyclodextrins in Pharmaceutical Revenue Market Share, 2022
Figure 48. Middle East & Africa Cyclodextrins in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 51. By Type, U.S. Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 55. By Type, Europe Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 57. China Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 59. By Type, China Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 63. By Type, Japan Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 67. By Type, South Korea Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 71. By Type, Southeast Asia Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 73. India Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India Cyclodextrins in Pharmaceutical Market Share, 2022
Figure 75. By Type, India Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Cyclodextrins in Pharmaceutical Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Cyclodextrins in Pharmaceutical Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia Cyclodextrins in Pharmaceutical Market Share, 2022
Fi
Research Methodology:
Global Cyclodextrins in Pharmaceutical Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|